TRDA Entrada Therapeutics, Inc.

NASDAQ

$4.78

Entrada Therapeutics, Inc. (TRDA) Earnings News

Earnings press releases, previews and reviews for Entrada Therapeutics, Inc. (TRDA), newest first.

Wednesday August 5, 2026 7:00 AM ET

Entrada Therapeutics Reports Second Quarter 2026 Financial Results

Thursday May 7, 2026 7:10 AM ET

Entrada Therapeutics Reports First Quarter 2026 Financial Results